Moleculin Biotech, Inc. Annual Return On Equity in % from 2016 to 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Moleculin Biotech, Inc. quarterly/annual Return On Equity history and growth rate from 2016 to 2024.
  • Moleculin Biotech, Inc. Return On Equity for the quarter ending December 31, 2024 was -165 %, a 104% decline year-over-year.
  • Moleculin Biotech, Inc. annual Return On Equity for 2024 was -165 %, a 104% decline from 2023.
  • Moleculin Biotech, Inc. annual Return On Equity for 2023 was -80.9 %, a 74% decline from 2022.
  • Moleculin Biotech, Inc. annual Return On Equity for 2022 was -46.5 %, a 144% decline from 2021.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2024 -165 -84.1 -104% Jan 1, 2024 Dec 31, 2024
2023 -80.9 -34.4 -74% Jan 1, 2023 Dec 31, 2023
2022 -46.5 -27.4 -144% Jan 1, 2022 Dec 31, 2022
2021 -19.1 +90.9 +82.7% Jan 1, 2021 Dec 31, 2021
2020 -110 -35.9 -48.4% Jan 1, 2020 Dec 31, 2020
2019 -74.1 -2.69 -3.77% Jan 1, 2019 Dec 31, 2019
2018 -71.4 -16.3 -29.5% Jan 1, 2018 Dec 31, 2018
2017 -55.1 -22.4 -68.4% Jan 1, 2017 Dec 31, 2017
2016 -32.7 Jan 1, 2016 Dec 31, 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.